EP3332006
Ný and-PD-L1 mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.8.2016EP published:
11.10.2023EP application number:
16832346.7
EP translation filed:
18.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
4.8.2036Expiry date:
4.8.2026Next due date:
31.8.2026
Title in English:
NOVEL ANTI-PD-L1 ANTIBODIESLanguage of the patent:
English
Timeline
Today
5.8.2016EP application
11.10.2023EP Publication
18.12.2023Translation submitted
15.1.2024Registration published
4.8.2026Expires
Owner
Name:
Wuxi Biologics (Shanghai) Co. Ltd.Address:
288 Fute Zhong Road Waigaoqiao Free Trade Zone, Shanghai 200131, CN
Name:
Wuxi Biologics Ireland LimitedAddress:
Mullagharlin, Dundalk, Co Louth A91 X56F, IE
Inventor
Name:
ZHENG, YongAddress:
Shanghai 201203, CN
Name:
LI, JingAddress:
Lexington, Massachusetts 02420, US
Name:
CHEN, ZhishengAddress:
Shanghai 200131, CN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/CN2015/086216Date:
6.8.2015Country:
WO
Supplementary protection
SPC number:
SPC494
Classification
Categories:
C12N 15/09, C07K 16/28, C12N 5/00, A61K 39/395, C12P 21/08, A61P 31/12, A61P 35/00, A61P 37/04
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 18.7.2024
Expires: 4.8.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 18.7.2025
Expires: 4.8.2026
Payer: Árnason Faktor ehf.